NASDAQ: DARE
Dare Bioscience Inc Earnings Dates, Reports, Calls

Dare Bioscience earnings were -$18.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest DARE earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$4.0M, down 8.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DARE reported annual earnings of -$4.1M, with -86.6% growth.

DARE earnings history

Current Revenue
-$17.7k
Current Earnings
-$18.6M
Current Profit Margin
105,099.6%

DARE Return on Equity

Current Company
N/A
Current Industry
-10.1%
Current Market
30.7%

DARE undefined

Current Company
-103.7%
Current Industry
-0.2%
DARE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DARE announces earnings.

DARE undefined

Current Company
298.06%
Current Industry
6.3%
DARE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DARE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DARE-$17.97M-$18.60MN/A-$2.15
RANI-$22.18M-$29.80MN/A-$0.99
CVKD-$14.10M-$14.11MN/A-$8.88
BOLD-$60.22M-$64.39MN/A-$2.78
RNTX-$60.69M-$59.15MN/A-$3.00

Dare Bioscience Earnings Reports & History FAQ

What were Dare Bioscience's earnings last quarter?

Dare Bioscience (NASDAQ: DARE) reported Q2 2025 earnings per share (EPS) of -$0.45, up 129.41% year over year. Total DARE earnings for the quarter were -$4.02 million. In the same quarter last year, Dare Bioscience's earnings per share (EPS) was $1.53.

If you're new to stock investing, here's how to buy Dare Bioscience stock.

Is Dare Bioscience profitable or losing money?

As of the last Dare Bioscience earnings report, Dare Bioscience is currently losing money. Dare Bioscience's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$18.60 million, a 158.34% increase year over year.

What was DARE's earnings growth in the past year?

As of Dare Bioscience's earnings date in Q3 2025, Dare Bioscience's earnings has grown year over year. DARE earnings in the past year totalled -$18.60 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.